SCOPUS 정보 검색 플랫폼

Expert Review of Vaccines

Volumn 10, Issue 8, 2011, Pages 1113-1114

Provenge: Combating prostate cancer with a vengeance?

(2) Schwaab, Thomas a Pili, Roberto a

a ROSWELL PARK CANCER INSTITUTE (United States)

Author keywords

immunomodulation; immunotherapy; prostate cancer; vaccine

Indexed keywords

ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN; PROSTVAC; PROVENGE; UNCLASSIFIED DRUG;

CANCER IMMUNOTHERAPY; CANCER SURVIVAL; DRUG COST; EDITORIAL; HUMAN; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER;

CANCER VACCINES; HUMANS; IMMUNOTHERAPY; MALE; PROSTATIC NEOPLASMS; TISSUE EXTRACTS;

EID: 80052058835 PISSN: 14760584 EISSN: 17448395 Source Type: Journal
DOI: 10.1586/erv.11.85 Document Type: Editorial

Times cited : (2)

References (8)

1
- 79952513499
- Current and emerging treatment modalities for metastatic castration-resistant prostate cancer
- Bracarda S, Logothetis C, Sternberg CN, Oudard S. Current and emerging treatment modalities for metastatic castration-resistant prostate cancer. BJU Int. 107(Suppl. 2), 13-20 (2011)
- (2011) BJU Int. , vol.107 , Issue.SUPPL. 2 , pp. 13-20
- Bracarda, S.¹ Logothetis, C.² Sternberg, C.N.³ Oudard, S.⁴

2
- 68049122447
- Renal cell carcinoma
- Kirkwood J (Ed.). Dunitz Publishers, London, UK
- Schwaab T, Atzpodien J. Renal cell carcinoma. In:Strategies in Immunoadjuvant Therapies . Kirkwood J (Ed.). Dunitz Publishers, London, UK (2000)
- (2000) Strategies in Immunoadjuvant Therapies
- Schwaab, T.¹ Atzpodien, J.²

3
- 77955066199
- Sipuleucel-T immunotherapy for castration-resistant prostate cancer
- Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363(5), 411-422 (2010)
- (2010) N. Engl. J. Med. , vol.363 , Issue.5 , pp. 411-422
- Kantoff, P.W.¹ Higano, C.S.² Shore, N.D.³

4
- 77949895922
- Overall survival analysis of a Phase II randomized controlled trial of a pxviral-based PSA-targeted immunotherapy in metastatic castration resistant prostate cancer
- Kantoff PW, Schuetz TJ, et al. Overall survival analysis of a Phase II randomized controlled trial of a pxviral-based PSA-targeted immunotherapy in metastatic castration resistant prostate cancer. J. Clin. Oncol. 28(7), 1099-1105 (2010)
- (2010) J. Clin. Oncol. , vol.28 , Issue.7 , pp. 1099-1105
- Kantoff, P.W.¹ Schuetz, T.J.²

5
- 30544449854
- A Phase i trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer
- DiPaola RS, Plante M, Kaufman H, et al. A Phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer. J. Transl. Med. 3, 4 (2006)
- (2006) J. Transl. Med. , vol.3 , pp. 4
- Dipaola, R.S.¹ Plante, M.² Kaufman, H.³

6
- 79251555315
- Recent developments in cancer vaccines
- Palucka K, Ueno H, Banchereau J. Recent developments in cancer vaccines. J. Immunol. 186(3), 1325-1331 (2011)
- (2011) J. Immunol. , vol.186 , Issue.3 , pp. 1325-1331
- Palucka, K.¹ Ueno, H.² Banchereau, J.³

7
- 80051621180
- Prostatic acid phosphatase expression in human tissues
- Graddis TJ, McMahan CJ, Tamman J, Page KJ, Trager JB. Prostatic acid phosphatase expression in human tissues. Int. J. Clin. Exp. Pathol. 4(3), 295-306 (2011)
- (2011) Int. J. Clin. Exp. Pathol. , vol.4 , Issue.3 , pp. 295-306
- Graddis, T.J.¹ McMahan, C.J.² Tamman, J.³ Page, K.J.⁴ Trager, J.B.⁵

8
- 79952269861
- Ipilimumab: A promising immunotherapy for melanoma
- Thumar JR, Kluger HM. Ipilimumab: a promising immunotherapy for melanoma. Oncology 24(14), 1280-1288 (2010)
- (2010) Oncology , vol.24 , Issue.14 , pp. 1280-1288
- Thumar, J.R.¹ Kluger, H.M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.